Filing Details
- Accession Number:
- 0001104659-24-115837
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-08 15:59:32
- Reporting Period:
- 2023-01-03
- Accepted Time:
- 2024-11-08 15:59:32
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1875558 | Nuvectis Pharma Inc. | NVCT | Pharmaceutical Preparations (2834) | 862405608 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1896079 | J. Michael Carson | C/O Nuvectis Pharma, Inc. 1 Bridge Plaza, Suite 275 Fort Lee NJ 07024 | Vice President, Finance | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-01-03 | 28,806 | $0.00 | 56,106 | No | 4 | A | Direct | |
Common Stock | Acquisiton | 2024-01-04 | 34,567 | $0.00 | 90,673 | No | 4 | A | Direct | |
Common Stock | Disposition | 2024-11-07 | 2,755 | $8.16 | 87,918 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | A | Direct | |
No | 4 | S | Direct |
Footnotes
- The 28,806 shares of restricted Common Stock will vest in equal annual installments over three years beginning on the first anniversary of the grant date subject to Mr. Carson's continued service on such dates.
- Includes shares of restricted common stock, which vest over various time periods.
- The 34,567 shares of restricted Common Stock will vest in equal annual installments over three years beginning on the first anniversary of the grant date subject to Mr. Carson's continued service on such dates.
- In connection with the vesting of 9,100 shares, 2,755 shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Carson's tax withholding obligations. Mr. Carson had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.